First Dollar Coverage for Chronic Disease Care: Can it Save Money and Improve Patient Outcomes?

Korey Capozza

Benefit-based interventions to address chronic disease compliance generally involve one of two approaches. The most common strategy is to exempt classes of drugs from copayments or coinsurance; a less tested strategy is to exempt classes of patients (i.e., diabetics) from cost sharing.

Do such interventions improve health outcomes, and do they save money? Several studies directly address these questions.

View the full report.